Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
APGA Annual ConferenceAPGA Annual Conference
Not Confirmed
Not Confirmed
20-23 July, 2025
Not Confirmed
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
APGA Annual ConferenceAPGA Annual Conference
Industry Trade Show
Not Confirmed
20-23 July, 2025
Industry Trade Show
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
24 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/rezolve-ad-phase-2b-study-of-rezpegaldesleukin-meets-primary-and-key-secondary-endpoints-in-patients-with-moderate-to-severe-atopic-dermatitis-302489015.html
23 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nektar-to-announce-top-line-data-from-the-16-week-induction-period-in-rezolve-ad-phase-2b-study-of-rezpegaldesleukin-a-regulatory-t-cell-proliferator-in-atopic-dermatitis-on-june-24-2025-302488592.html
08 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nektar-therapeutics-reports-first-quarter-2025-financial-results-302450173.html
24 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nektar-announces-clinical-trial-agreement-to-evaluate-rezpegaldesleukin-in-patients-with-new-onset-type-1-diabetes-mellitus-302383052.html
10 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nektar-therapeutics-receives-fast-track-designation-for-rezpegaldesleukin-for-the-treatment-of-moderate-to-severe-atopic-dermatitis-302371995.html
02 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ampersand-capital-partners-completes-acquisition-of-nektar-therapeutics-peg-reagent-manufacturing-business-launching-newly-branded-gannet-biochem-302319679.html
Excipients
Inspections and registrations
ABOUT THIS PAGE
Nektar Therapeutics is a supplier offers 6 products (APIs, Excipients or Intermediates).
Find a price of NKTR-255 DRUG PRODUCT bulk with DMF offered by Nektar Therapeutics
Find a price of NKTR-255 DRUG SUBSTANCE bulk with DMF offered by Nektar Therapeutics
Find a price of Amikacin bulk offered by Nektar Therapeutics
Find a price of Lysine bulk offered by Nektar Therapeutics
Find a price of Macrogol bulk offered by Nektar Therapeutics
Find a price of PEG2MAL40K bulk offered by Nektar Therapeutics